Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
82,204,789
-
Share change
-
-6,146,033
-
Total reported value
-
$1,104,755,817
-
Put/Call ratio
-
31%
-
Price per share
-
$13.44
-
Number of holders
-
241
-
Value change
-
-$95,343,724
-
Number of buys
-
115
-
Number of sells
-
125
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2023
As of 30 Jun 2023,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
241 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,204,789 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, GOLDMAN SACHS GROUP INC, and Invesco Ltd..
This page lists
243
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.